Allworth Financial LP Sarepta Therapeutics, Inc. Transaction History

Allworth Financial LP

$22 Billion
Q3 2025

A detailed history of Allworth Financial LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 1,803 shares of SRPT stock, worth $33,914. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,803

Previous 82 2098.78%

Holding current value

$33,914

Previous $1,000 3300.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Dec 02, 2025	BUY	$11.93 - $21.97 $20,531 - $37,810	1,721 Added 2098.78%	1,803 $34,000
Q2 2025 Aug 07, 2025	SELL	$17.1 - $63.66 $2,103 - $7,830	-123 Reduced 60.0%	82 $1,000
Q1 2025 Apr 30, 2025	BUY	$63.82 - $127.89 $4,658 - $9,335	73 Added 55.3%	205 $13,000
Q4 2024 Jan 30, 2025	BUY	$104.54 - $137.94 $5,227 - $6,897	50 Added 60.98%	132 $16,000
Q3 2024 Oct 23, 2024	BUY	$124.33 - $156.75 $2,113 - $2,664	17 Added 26.15%	82 $10,000

Q2 2024 Jul 23, 2024	BUY	$113.33 - $163.85 $2,606 - $3,768	23 Added 54.76%	65 $10,000
Q1 2024 Apr 25, 2024	SELL	$93.7 - $141.53 $4,497 - $6,793	-48 Reduced 53.33%	42 $5,000
Q4 2023 Jan 24, 2024	BUY	$67.31 - $124.76 $605 - $1,122	9 Added 11.11%	90 $8,000
Q3 2023 Oct 31, 2023	BUY	$102.5 - $123.59 $4,612 - $5,561	45 Added 125.0%	81 $9,000
Q2 2023 Jul 18, 2023	SELL	$106.4 - $157.19 $851 - $1,257	-8 Reduced 18.18%	36 $4,000
Q1 2023 Apr 18, 2023	BUY	$117.53 - $155.99 $1,998 - $2,651	17 Added 62.96%	44 $6,000
Q4 2022 Jan 13, 2023	SELL	$100.86 - $132.13 $302 - $396	-3 Reduced 10.0%	27 $0
Q3 2022 Oct 18, 2022	BUY	$75.71 - $119.24 $1,817 - $2,861	24 Added 400.0%	30 $3,000
Q2 2022 Jul 13, 2022	SELL	$62.69 - $88.44 $10,343 - $14,592	-165 Reduced 96.49%	6 $0
Q1 2022 Apr 22, 2022	BUY	$63.15 - $90.42 $10,798 - $15,461	171 New	171 $13,000
Q4 2021 Jan 21, 2022	SELL	$77.28 - $99.42 $48,995 - $63,032	-634 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$65.97 - $92.48 $8,905 - $12,484	135 Added 27.05%	634 $59,000
Q2 2021 Aug 02, 2021	SELL	$69.38 - $86.75 $13,876 - $17,350	-200 Reduced 28.61%	499 $39,000
Q3 2017 Oct 12, 2017	BUY	$35.73 - $47.15 $10,718 - $14,145	300 Added 75.19%	699 $32,000
Q2 2017 Aug 07, 2017	BUY	N/A	399	399 $13,000

Others Institutions Holding SRPT

# of Institutions

412

Shares Held

83.8M

Call Options Held

5.27M

Put Options Held

5.94M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.65B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.

Account

Allworth Financial LP Sarepta Therapeutics, Inc. Transaction History